Resmed RMD Ratios (2009-2026)

NYSE RMD
$246.28 +0.78 (+0.32%)
As of: Oct 21, 2026 · 3:59 PM EDT
Reported Financials

Resmed Quarterly Ratios

Periods 68 quarters
Latest Jun 2026

Resmed reported a gross margin of 58.84% and a net margin of 26.20% for the quarter ended Jun 2026. These financial ratios cover 68 quarters of results from Sep 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
56.00%56.36%56.82%57.12%56.91%56.08%55.31%55.02%54.44%55.64%57.88%58.50%58.57%58.60%59.33%60.84%61.46%61.76%62.25%58.84%
EBT Margin
28.63%26.52%26.18%26.03%27.55%26.48%25.91%24.67%24.69%22.31%31.36%29.25%31.32%32.63%32.34%33.98%33.45%34.87%35.09%32.40%
EBIT Margin
28.97%27.79%27.10%27.92%29.02%27.10%26.92%24.53%26.22%23.66%31.29%31.17%31.63%32.54%33.00%33.72%33.43%34.56%34.92%30.66%
EBITDA Margin
33.30%32.35%31.99%32.01%32.83%30.76%30.89%28.70%30.29%27.51%34.93%34.74%35.28%36.17%36.38%38.44%37.01%38.06%39.04%33.72%
Operating Margin
28.97%27.79%27.10%27.92%29.02%27.10%26.92%24.53%26.22%23.66%31.29%31.17%31.63%32.54%33.00%33.72%33.43%34.56%34.92%30.66%
Net Margin
22.52%22.55%20.71%21.32%22.15%21.76%20.82%20.47%19.91%17.96%25.10%23.89%25.43%26.88%28.26%28.17%26.10%27.59%27.86%26.20%
FCF Margin
-10.29%21.17%7.98%5.56%1.64%9.80%22.72%18.09%23.25%21.46%31.82%33.95%25.13%22.46%43.19%37.70%31.02%21.87%36.36%27.57%
Efficiency
Inventory AverageInventory Avg.
481.84M549.40M628.54M704.43M804.38M926.90M1,000.11M1,004.64M978.12M945.72M881.34M825.85M870.12M900.04M872.37M895.18M936.76M933.93M916.96M928.84M
Assets AverageAssets Avg.
4,728.65M4,731.95M4,820.00M5,000.56M5,136.71M5,926.83M6,694.99M6,732.79M6,746.25M6,822.94M6,859.83M6,843.48M7,047.41M7,181.88M7,354.08M7,870.61M8,241.37M8,405.86M8,643.83M8,875.12M
Equity AverageEquity Avg.
2,955.86M3,085.94M3,212.32M3,319.78M3,396.82M3,585.51M3,835.32M4,031.21M4,190.14M4,366.12M4,555.89M4,746.98M5,029.53M5,224.02M5,399.57M5,757.00M6,044.56M6,221.07M6,406.40M6,538.65M
Invested CapitalInvested Cap.
3,831.72M3,825.81M3,959.51M4,135.99M4,228.23M5,538.72M5,518.37M5,571.04M5,611.79M5,708.52M5,636.87M5,571.26M5,872.50M5,925.77M6,219.17M6,636.15M6,789.82M6,984.71M7,156.01M7,244.76M
Asset Utilization RatioAsset Util.
0.710.730.730.720.710.630.600.630.650.660.670.680.680.690.680.650.640.640.640.64
Leverage & Solvency
Interest Coverage RatioInterest Cover
48.8641.8142.89
Debt Ratio
0.170.140.140.150.150.270.240.210.200.180.150.100.090.090.090.080.080.080.080.07
Times Interest Earned
48.8641.8142.89
Valuation
Price to EarningsP/E
76.8472.9645.5139.3840.6637.7737.2835.8023.9928.4230.3527.5432.2026.9024.9926.9627.7823.6121.4318.45
Price to SalesP/S
11.4711.0610.028.588.828.128.017.614.975.626.356.007.456.826.547.347.606.505.884.97
Price to BookP/B
12.6912.1110.829.139.318.188.187.785.125.656.285.786.906.395.926.336.535.555.024.27
Enterprise Value
38,126.04M37,890.87M35,269.21M30,418.37M31,764.84M30,321.33M31,947.08M31,905.67M21,540.37M25,091.75M28,850.05M27,881.44M35,404.63M33,062.63M31,887.90M36,557.97M38,564.49M33,668.48M30,898.12M26,640.17M
EV to EBIT
40.1938.8435.7530.4131.3229.0028.7328.1918.8122.0123.7721.1224.9621.1919.7821.6922.1118.5116.3314.12
EV to EBITDA
34.5033.4630.7926.2327.1325.2825.2024.6016.3319.0020.7018.6322.2019.0217.8119.4119.8216.6414.6212.76
Market Capitalization
38,402.19M38,085.35M35,470.98M30,692.08M31,972.01M30,574.53M32,174.98M32,133.56M21,749.47M25,301.99M29,087.96M28,119.80M35,830.99M33,584.57M32,820.61M37,767.42M39,948.34M35,085.54M32,558.63M28,109.41M
Price to FCFP/FCF
93.5581.9097.42141.8998.40129.1576.3456.0226.7126.2926.7021.6026.4824.1320.9222.7322.5919.5818.5617.04
EV to FCF
92.8781.4896.87140.6297.76128.0875.8055.6226.4526.0726.4821.4226.1623.7620.3322.0021.8118.7917.6116.15
EV to CFO
72.3465.6770.8086.6368.8381.9059.6846.0223.0423.2524.0719.9024.5822.4019.2920.8720.4817.5916.3514.75
Return Ratios
Return on Sales [ROS]ROS
28.97%27.79%27.10%27.92%29.02%27.10%26.92%24.53%26.22%23.66%31.29%31.17%31.63%32.54%33.00%33.72%33.43%34.56%34.92%30.66%
Return on Capital Employed [ROCE]ROCE
23.11%23.73%23.76%23.20%22.82%20.13%18.74%18.95%19.16%18.82%19.94%22.25%23.09%24.65%25.13%24.60%24.97%25.41%25.95%25.22%
Return on Invested Capital [ROIC]ROIC
13.88%13.95%20.54%20.05%19.79%17.33%16.33%16.63%16.69%16.34%17.32%19.01%20.04%21.52%22.10%21.89%21.47%21.58%21.37%20.80%
Return on Assets [ROA]ROA
10.57%11.03%16.17%15.59%15.31%13.66%12.89%13.33%13.44%13.05%13.97%14.92%15.79%17.39%17.86%17.80%17.45%17.68%17.58%17.16%
Return on Equity [ROE]ROE
16.91%16.91%24.27%23.48%23.15%22.58%22.50%22.27%21.63%20.39%21.04%21.51%22.13%23.90%24.32%24.33%23.79%23.88%23.72%23.30%

Resmed Ratios API

Pull Resmed's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RMD&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY